Clinical Trial Update: Use of a New Phototherapy Device (BBloo®) for the Treatment of Hyperbilirubinemia in the Newborn Infant [Phase 4]

View source ↗

Summary

This update reports on a Phase 4 clinical trial evaluating the BBloo phototherapy device for treating neonatal hyperbilirubinemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hyperbilirubinemia

Drugs mentioned

• BBloo® Phototherapy Device

Snippet

Sponsor: Association Pédiatrique des Groupes d'Acuueil et de Recherche | Conditions: Neonatal Hyperbilirubinemia | Phase 4 | Status: UNKNOWN